Concepedia

Youssef M.K. Farag

YM

Statistics

Publications

8

Citations

677

H-Index

8

Active since

2019

Affiliations

Akebia Therapeutics (United States)(Current)

Johns Hopkins University

Indiana University – Purdue University Indianapolis

Charité - Universitätsmedizin Berlin

Vanderbilt University Medical Center

Youssef M.K. Farag is an author at Akebia Therapeutics (United States) specializing in medicine, pharmacology, and hemodialysis.

ORCID

Publications per year

2019–2023

8

Publications

8

Vadadustat in Patients with Anemia and Non–Dialysis-Dependent CKD

Glenn M. Chertow, Pablo E. Pérgola, Youssef M.K. Farag et al. · New England Journal of Medicine · 2021 · 238 citations · Full text

, , +11

Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis

Kai‐Uwe Eckardt, Rajiv Agarwal, Ahmad Aswad et al. · New England Journal of Medicine · 2021 · 197 citations · Full text

, , +17

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat et al. · Annals of Internal Medicine · 2023 · 88 citations

, , +17

Vadadustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, for treatment of anemia of chronic kidney disease: two randomized Phase 2 trials in Japanese patients

Masaomi Nangaku, Youssef M.K. Farag, Emil M. deGoma et al. · Nephrology Dialysis Transplantation · 2020 · 40 citations

, , +9

Global Dialysis Perspective: Egypt

Youssef M.K. Farag, Enass Elsayed · Kidney360 · 2022 · 40 citations · Full text

, , +4

1–5 of 8